Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway

Publication date: Available online 30 August 2020Source: Molecular and Cellular EndocrinologyAuthor(s): Shao-Hua Fan, Qian-Feng Xiong, Lei Wang, Li-Hui Zhang, Ya-Wei Shi

Source: Molecular and Cellular Endocrinology - August 30, 2020 Category: Endocrinology Source Type: research